Ovid Therapeutics Other Current Borrowings (Quarterly) Insights

Ovid Therapeutics, Inc. (OVID)

1.525 +0.08 (+5.17%) USD | NASDAQ | Feb 24, 12:20

View Other Current Borrowings (Quarterly) for OVID.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Borrowings (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Borrowings (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Borrowings (Quarterly) Benchmarks

Start Trial

Cassava Sciences, Inc.	--
PTC Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--